The GLP-1 landscape in July 2026 has more options than ever — and more confusion to match. Brand pills, brand injections, compounded injections, Medicare Bridge, manufacturer savings cards, TrumpRx, employer coverage, and more. Here's a systematic way to find your best pathway.

Step 1: What Insurance Do You Have?

Medicare Part D
Start with the Medicare GLP-1 Bridge. If you meet the BMI criteria (35+, or 30+ with certain conditions, or 27+ with cardiovascular history), you can access Wegovy, Zepbound, or Foundayo for $50/month. This is the cheapest option available for qualifying Medicare beneficiaries. If you don't qualify for the Bridge, compounded options are your primary self-pay alternative.
Commercial/Employer Insurance
Check whether your plan covers GLP-1 medications for weight loss. If yes, use manufacturer savings cards (NovoCare or LillyDirect) to reduce your copay to $0–$25/month. If your plan doesn't cover weight loss medications, check whether it covers GLP-1s for other indications (diabetes, cardiovascular risk). If no coverage exists, proceed to self-pay options.
Uninsured or Underinsured
Your primary options are: Compounded semaglutide ($99–$249/month depending on dose), Wegovy pill self-pay ($149–$349/month), Foundayo self-pay ($149–$349/month), or TrumpRx ($149–$449/month). Compounded is typically cheapest at therapeutic doses. Brand options are worth comparing at starter doses.

Step 2: What Are Your Priorities?

Once you know your insurance situation, the next question is what matters most to you:

Maximum weight loss → Semaglutide (injectable) or tirzepatide. The clinical data for these two molecules shows the strongest weight reduction. Available as brand (Wegovy injection, Zepbound) or compounded.

Lowest possible cost → Medicare Bridge ($50) if eligible, otherwise compounded semaglutide ($99–$149 at starter doses). Brand options at therapeutic doses are almost always more expensive than compounded.

No needles → Foundayo (no food restrictions, any time of day) or Wegovy pill (morning fasting required). Foundayo's convenience is significantly better for most lifestyles.

FDA approval → Any brand product (Wegovy, Zepbound, Foundayo, Ozempic, Mounjaro). Compounded medications are legal but not FDA-approved.

Custom dose control → Compounded only. Brand products come in fixed dose increments. Compounded allows titration in any increment your provider prescribes.

Step 3: Match Your Profile

Patient ProfileBest OptionMonthly Cost
Medicare + BMI qualifiesMedicare Bridge$50
Good commercial insuranceBrand + savings card$0–$25
Insurance covers diabetes, not weight lossTalk to provider about indication codingVaries
Uninsured, budget-consciousCompounded semaglutide$99–$199
Uninsured, no needlesFoundayo self-pay$149–$349
Uninsured, max efficacyCompounded tirzepatide$149–$399
Previous brand intoleranceCompounded (custom dose)$99–$249

Ready to Compare?

See pricing for your specific situation across every pathway available in July 2026.

Find Your Best Option →